Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm, Residual × Docetaxel × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gynecologic 1

Conditions

Ovarian Neoplasms 52 Carcinoma, Ovarian Epithelial 25 Fallopian Tube Neoplasms 19 Uterine Cervical Neoplasms 15 Endometrial Neoplasms 15 Breast Neoplasms 10 Stomach Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Prostatic Neoplasms 7 Lung Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Peritoneal Neoplasms 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Esophageal Neoplasms 6 Carcinoma, Renal Cell 6 Melanoma 5 Uterine Neoplasms 4 Urinary Bladder Neoplasms 4 Neoplasms 4 Triple Negative Breast Neoplasms 3 Small Cell Lung Carcinoma 3 Sarcoma 3 Pancreatic Neoplasms 3 Kidney Neoplasms 3 Head and Neck Neoplasms 3 Esthesioneuroblastoma, Olfactory 3 Colorectal Neoplasms 3 Carcinoma, Transitional Cell 3 Brenner Tumor 3 Salivary Gland Neoplasms 2

Interventions

Neoadjuvant Therapy 1 Docetaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00551577 2007-10-31

PRIMOVAR-1

University Hospital, Bonn

Phase 2 Unknown

Ovarian Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡